NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-157-1993-1-CH-27 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE CH EP 95909917.7 Abandoned
NCI E-157-1993-1-FR-16 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE FR EP 95909917.7 Abandoned
NCI E-157-1993-1-DE-17 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE DE EP 95909917.7 Abandoned
NCI E-157-1993-1-DK-15 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE DK EP 95909917.7 Abandoned
NCI E-157-1993-1-AT-13 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE AT EP 95909917.7 Abandoned
NCI E-157-1993-1-BE-14 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE BE EP 95909917.7 Abandoned
NCI E-157-1993-1-IT-20 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE IT EP 95909917.7 Abandoned
NCI E-157-1993-1-GR-18 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE GR EP 95909917.7 Abandoned
NCI E-157-1993-1-IE-19 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE IE EP 95909917.7 Abandoned
NCI E-157-1993-1-EP-12 MIXTURES OF DIDEOXY-NUCLEOSIDES AND HYDROXYCARBAMIDE FOR INHIBITING RETROVIRAL SPREAD EP National Stage 95909917.7 Abandoned
NCI E-157-1993-1-CA-11 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYCARBAMIDE CA National Stage 2179627 Abandoned
NCI E-220-1994-0-US-01 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS... US ORD 08/359,612 5728718 Abandoned PDF
NCI E-157-1993-1-TW-06 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE TW ORD 83111742 Abandoned
NCI E-157-1993-1-ZA-07 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE ZA National Stage 94/9219 Abandoned
NIDDK E-045-1989-0-US-03 SULFUR-CONTAINING XANTHINE DERIVATIVES AS ADENOSINE ANTAGONISTS US FWC 08/359,959 5453426 Expired PDF
NCI E-157-1993-1-PCT-03 MIXTURES OF DIDEOXY-NUCLEOSIDES AND HYDROXYCARBAMIDE FOR INHIBITING RETROVIRAL SPREAD PCT PCT PCT/IB1995/000153 Abandoned
NCI E-157-1993-1-OA-05 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE OA National Stage 60849 Abandoned
NIAID E-189-1992-0-US-07 SYNTHETIC PEPTIDE VACCINE FOR CHLAMYDIA TRACHOMATIS US FWC 08/363,307 Abandoned
NCI E-157-1993-1-BR-04 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE BR National Stage PI1100041-4 Abandoned
NCI E-157-1993-1-AU-10 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE AU National Stage 18212/95 Abandoned
NCI E-046-1995-0-US-01 SCREENING ASSAYS FOR COMPOUNDS THAT CAUSE APOPTOSIS AND RELATED COMPOUNDS US ORD 08/359,316 6602979 Abandoned PDF
NCI E-136-1992-0-US-07 TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND OTHER PRIMITIVE NEURAL MALIGNANCIES US FWC 08/358,657 Abandoned
NHLBI E-232-1994-0-US-01 CHIRAL SEPARATION OF ENANTIOMERS BY HIGH-SPEED COUNTERCURRENT CHROMATOGRAPHY US ORD 08/357,845 6337021 Abandoned PDF
CC E-088-1994-1-US-01 VARIABLE AXIAL APERTURE POSITRON EMISSION TOMOGRAPHY SCANNER US CIP 08/357,574 5591977 Expired PDF
NCI E-216-1994-0-US-01 INHIBITION OF RETROVIRAL LTR PROMOTERS BY CALCIUM RESPONSE MODIFIERS US ORD 08/353,765 6057346 Abandoned PDF
NCI E-032-1995-0-US-01 SENSITIVE ASSAY FOR MEASURING GALLIUM LEVELS IN BODY TISSUES AND FLUIDS US ORD 08/355,153 5650627 Expired PDF
NIA E-239-1994-0-US-01 RESOLUTION AND REDUCTION OF PHYSOSTIGMINE INTERMEDIATES AND DERIVATIVES US ORD 08/350,819 5571929 Expired PDF
NIDDK E-245-1992-0-US-03 ARALKYL DIAZABICYCLOALKANE DERIVATIVES FOR CNS DISORDERS US CON 08/348,654 5679679 Abandoned PDF
NCI E-162-1990-0-US-08 SUSTAINED AND CONTINUOUS PRODUCTION OF HIGH TITERS OF RECOMBINANT VIRAL VECTORS AND TRANSDUCED TARGET CELLS... US FWC 08/352,160 Abandoned
NIDDK E-245-1993-0-US-02 NITROGEN-CONTAINING CYCLOHETERO ALKY FUSED CYCLOAMINOARYL DERIVATIVES FOR CNS DISORDERS US CON 08/348,622 Abandoned
NHLBI E-006-1993-0-US-03 MULTIFINGER TOPOCATHERTER TIP FOR MULTILUMEN CATHETER FOR ANGIOPLASTY AND MANIPULATION US FWC 08/352,784 5437638 Expired PDF
NCI E-181-1989-0-US-05 ANTIGEN AND IMMUNOASSAY FOR HIV-2 US FWC 08/348,504 Abandoned
NIAID E-151-1992-0-US-11 INTERLEUKIN-4 STIMULATED T LYMPHOCYTE CELL DEATH FOR THE TREATMENT OF ALLERGIC DISORDERS US FWC 08/348,286 5935575 Abandoned PDF
NIEHS E-171-1994-0-US-01 ULTRASELECTIVE OPIOIDMIMETIC PEPTIDES AND PHARMACOLOGICAL AND THERAPEUTIC USES THEREOF US ORD 08/347,531 5780589 Expired PDF
NIAID E-185-1994-0-US-01 SERIALLY PASSAGED AFRICAN GREEN MONKEY KIDNEY CELLS WHICH ARE A SUBSTRATE FOR GROWTH OF VIRUSES AND PREPARATION OF VIRAL VACCINES US ORD 08/351,079 5646033 Expired PDF
NIMH E-241-1995-1-US-01 GLYCOLIPID ENZYME-POLYMER CONJUGATES US CIP 08/346,680 5620884 Expired PDF
NEI E-101-1990-0-US-03 Anti-Viral Therapy US CON 08/348,838 5529771 Expired PDF
NIEHS E-237-1994-5-US-01 ISOLATION OF BRCA1 GENE AND ITS INVOLVEMENT IN SPORADIC BREAST AND OVARIAN CANCER US CIP 08/348,824 Expired
NCI E-142-1990-2-US-01 AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY US CIP 08/346,455 5731167 Expired PDF
NCI E-212-1994-0-US-01 TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS US ORD 08/348,960 Abandoned
NHLBI E-225-1994-0-US-01 LIPID VESICLES CONTAINING ADENO-ASSOCIATED VIRUS REP PROTEIN FOR TRANSGENE INTEGRATION AND GENE THERAPY US ORD 08/344,729 6342390 Expired PDF
NIDDK E-050-1988-0-US-03 N-(1-THIENYLCYCLOALKYL)ALKENYLAMINES FOR TREAMENT OF NEUROTOXIC INJURY US DIV 08/344,433 5604255 Expired PDF
NCI E-186-1993-0-US-03 RESTORATION OF IMMUNOCOMPETENCY TO T HELPER CELLS IN HIV INFECTED PATIENTS US FWC 08/344,794 Abandoned
NHLBI E-064-1994-1-US-02 ADENO-ASSOCIATED VIRUS CAPABLE OF EXPRESSING AT LEAST ONE GLOBIN GENE AND METHODS OF PRODUCING AND USING THE SAME FOR GENE THERAPY US CON 08/344,816 Abandoned
NIDDK E-138-1992-1-US-01 Xanthines For Identifying CFTR-Binding Compounds Useful For Activating Chloride Conductance IN Animal Cells US CIP 08/343,714 5877179 Abandoned PDF
NCI E-020-1995-0-US-01 USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK US ORD 08/344,341 5700830 Abandoned PDF
NCI E-196-1992-3-US-01 BIOPOLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF.... US CIP 08/344,157 5632981 Abandoned PDF
NIDDK E-246-1992-0-US-03 ARALKYL BRIDGED DIAZABICYCLOAKANE DERIVATIVES FOR CNS DISORDERS US CON 08/344,304 5679673 Abandoned PDF
NCI E-012-1993-0-US-04 METHOD FOR TREATING TAXOL SIDE-EFFECTS WITH G-CSF US FWC 08/342,797 5496804 Expired PDF
NHLBI E-052-1994-0-PCT-02 VECTOR SYSTEMS FOR THE GENERATION OF ADENO-ASSOCIATED VIRUS PARTICLES PCT PCT PCT/US1994/013516 Expired